Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas;Ruolo dell'imaging pesato in perfusione a 3 Tesla nella valutazione del grado di malignità dei gliomi cerebrali

Radiologia Medica

Volumn 113, Issue 1, 2008, Pages 134-143

  Di Costanzo, A ^a   Pollice, S ^b   Trojsi, F ^c   Giannatempo, G M ^d   Popolizio, T ^d   Canalis, L ^b   Armillotta, M ^d   Maggialetti, A ^e   Carriero, A ^b   Tedeschi, G ^c   Scarabino, T ^d,e  

^a UNIVERSITY OF MOLISE   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e Ospedale L Bonomo   (Italy)

Author keywords

Brain tumour; Cerebral blood volume; Magnetic resonance imaging; Perfusion magnetic resonance imaging

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; BLOOD VOLUME; BRAIN CIRCULATION; BRAIN EDEMA; BRAIN NECROSIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOMA; HEMODYNAMICS; HUMAN; MALE; PERFUSION WEIGHTED IMAGING; TUMOR DIFFERENTIATION; WHITE MATTER;

ADULT; AGED; ASTROCYTOMA; BLOOD VOLUME; BRAIN EDEMA; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; ECHO-PLANAR IMAGING; FEMALE; GADOLINIUM DTPA; GANGLIOGLIOMA; GLIOBLASTOMA; GLIOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECROSIS; OLIGODENDROGLIOMA; RETROSPECTIVE STUDIES;

EID: 40749103837     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-008-0232-2     Document Type: Article

References (31)

1. Hess KR, Broglio KR, Bondy ML (2004) Adult glioma incidence trends in the United States, 1977-2000. Cancer 101:2293-2299
2. Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475-487
3. Ginsberg LE, Fuller GN, Hashmi M et al (1998) The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49:436-440
4. Cha S, Knopp EA, Johnson G et al (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29
5. Covarrubias DJ, Rosen BR, Lev MH (2004) Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9:528-537
6. Barbier E, Lamalle L, Decorps M (2001) Methodology of brain perfusion imaging. J Magn Reson Imaging 13:496-520
7. Aronen HJ, Gazit I, Louis D et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51
8. Sugahara T, Korogi Y, Kochi M et al (1998) Correlation of MR imagingdetermined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479-1486
9. Knopp EA, Cha S, Johnson G et al (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791-798
10. Aprile I, Muti M, Principi M et al (2002) Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas. Radiol Med (Torino) 104:87-91
11. Preul C, Kühn B, Lang EW et al (2003) Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. Eur J Radiol 48:244-251
12. Principi M, Italiani M, Guiducci A et al (2003) Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas. Neuroradiology 45:205-211
13. Schmainda KM, Rand SD, Joseph AM et al (2004) Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 25:1524-1532
14. Law M, Yang S, Babb JS et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746-755
15. Bulakbasi N, Kocaoglu M, Farzaliyev A et al (2005) Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 26:2187-2199
16. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859-867
17. Hakyemez B, Erdogan C, Bolca N et al (2006) Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 24:817-824
18. Leon SP, Folkerth RD, Black PM (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-372
19. Lev MH, Ozsunar Y, Henson JW et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 25:214-221
20. Scarabino T, Giannatempo GM, Nemore F et al (2003) 3.0 Tesla Magnetic Resonance. Part 2: morphological and functional brain. Radiol Med (Torino) 105:150-161
21. DeLano MC, Fisher C (2006) 3T MR imaging of the brain. Magn Reson Imaging Clin N Am 14:77-88
22. Scarabino T, Giannatempo GM, Popolizio T et al (2007) 3.0 T functional brain imaging: a five-year experience. Radiol Med (Torino) (in press)
23. Frayne R, Goodyear BG, Dickhoff P et al (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385-402
24. Scarabino T, Maiorana A, Nemore F et al (2003) 3.0 Tesla Magnetic Resonance. Part I: safety problems related to installation and use. Radiol Med (Torino) 105:141-149
25. Uematsu H, Maeda M (2006) Doubleecho perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability. Eur Radiol 16:180-186
26. Keston P, Murray AD, Jackson A (2003) Cerebral perfusion imaging using contrast-enhanced MRI. Clin Radiol 58:505-513
27. Sorensen AG, Reimer P (2000) Cerebral MR perfusion imaging: principles and current applications. Georg Thieme Verlag, Stuttgart, Germany
28. Manka C, Träber F, Gieseke J et al (2005) Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose. Radiology 234:869-877
29. Strugar JG, Criscuolo GR, Rothbart D, Harrington WN (1995) Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 83:682-689
30. Chiang IC, Kuo Y-T, Lu C-Y et al (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 46:619-627
31. Law M, Cha S, Knopp EA et al (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721